Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00232115 | Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis | PHASE3 | COMPLETED | 124 | — | — | Sep 1, 2005 | Jul 1, 2006 | Jan 17, 2008 | 1 | Germany |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Pimecrolimus |
| 2 | PLACEBO_COMPARATOR | Vehicle |
| Name | Type | Description |
|---|---|---|
| Pimecrolimus | DRUG | Pimecrolimus cream 1 % |
| Placebo | DRUG | Vehicle cream (placebo) |
Inclusion Criteria: * clinically diagnosed perioral dermatitis associated or not associated with topical steroid use (the periorbital area may also be involved in addition to the perioral region) * minimum severity score (PODSI) ≥ 4 * age 18 and older Exclusion Criteria: * Ongoing use of the foll...